Just Breathe: New Device Diagnoses Lung Diseases Using Breath

Biomedical engineering is bringing gas chromatography technology bedside, potentially making detection of certain conditions dramatically easier.

1:00 PM

Author | Alexandra Nowlin

Hand-held breathalyzers have been used for decades to measure the alcohol in a person's bloodstream. But what if they were able to detect illness?

MORE FROM THE LAB: Subscribe to our weekly newsletter

Researchers at the University of Michigan have developed a point-of-care device that can do just that: diagnose life-threatening lung diseases using only a patient's breath.

Exhaled breath contains hundreds of volatile organic compounds that carry important information about our physiology. Diseases can impact volatile organic compound combinations and create unique patterns known as breathomic signatures.

Kevin Ward, M.D., executive director of the Michigan Center for Integrative Research in Critical Care and professor of emergency medicine and biomedical engineering, partnered with Xudong Fan, Ph.D., associate director of MCIRCC and professor of biomedical engineering, to develop a device that recognizes and analyzes breathomic signatures to help guide diagnosis.

While the technology, known as gas chromatography, has existed for years, the machines have never been practical for bedside monitoring. Ward and Fan have re-engineered this technology to analyze vapor molecules in parts per billion.

"We're able to get high-fidelity results in a much smaller package, and there's no additional cost to the patient," Fan says.

The researchers think the device could help detect diseases such as acute respiratory distress syndrome (ARDS) days before physicians could make the diagnosis on their own.

ARDS causes a buildup of fluid in the alveoli of the lungs, making it difficult for oxygen to reach other organs. The American Lung Association estimates 200,000 patients are diagnosed with ARDS each year. The disease is notoriously difficult to detect, which is why it has such a high morbidity rate — 30 to 50 percent of patients die from the disease.

"ARDS is one of those diseases with a man-made definition," Ward says. "You can't run a simple blood test or biopsy the lung, so it's often tough to catch before it's too late. Even conventional chest X-rays change late and can be difficult to interpret."

SEE ALSO: Predicting — and Preventing — Psychiatric Morbidity After ARDS

And unlike biopsies or blood, breath can be collected easily and continuously, making it an ideal sample.

We're able to get high-fidelity results in a much smaller package, and there's no additional cost to the patient.
Xudong Fan, Ph.D.

'Breath-by-breath' progress

Ward and Fan's micro-gas chromatography device is fully automated and weighs only 9 pounds. The device uses an algorithm that can generate diagnostic results in less than 20 minutes, so monitoring takes place in real time. It is also useful for monitoring patient trajectory once treatment has begun.

"Once you're able to confirm the ARDS diagnosis and begin treating the patient, it can take a while to know if your treatment changes are working," Ward says. "This device enables a breath-by-breath way to track progress, and you can know very early whether you're going in the right direction."

Additional team members include Robert Dickson, M.D., assistant professor of internal medicine and associate director of MCIRCC. Dickson is an expert in critical care and the role of the microbiome in ARDS and sepsis.

Although treating ARDS is their main focus, Ward and Fan envision this device improving outcomes for other inflammatory diseases such as pneumonia, sepsis and asthma.

The team, initially funded by Fast Forward Medical Innovation's Michigan Translational Research and Commercialization program, has also received funding from the National Institutes of Health's Centers for Accelerated Innovations based at the Cleveland Clinic.

The data to date have been so promising that the team recently received a National Institutes of Health R21 exploratory/developmental grant to advance the technology and test it in more patients. The team has several pending patents and is exploring starting a company around the technology.


More Articles About: Health Tech Lungs and Breathing Critical Care Acute Respiratory Distress Syndrome Breathing Device Emergency & Trauma Care
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories computer
Health Lab
Same patient. Different visit. Different race and ethnicity?
Data on the race and ethnicity of patients underpins efforts to reduce health care disparities, but a study shows inconsistent recording in emergency departments
Girl participates in rehab activities, playing with shapes on a board and using an exercise ball
Health Lab
Pediatric neuro rehabilitation program provides answers for 10-year-old with a traumatic brain injury
The University of Michigan Health Milestones Pediatric Neuro Rehabilitation Program specializes in evaluating and treating children with an acute neurological diagnosis from an injury or illness.
colorful illustration with human figure and highlighted lungs
Health Lab
Multimodal AI model may guide personalized treatments for tuberculosis
AI approach helps researchers interpret large biomedical data sets to accurately predict tuberculosis treatment prognosis
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
An unconscious woman lies on a hospital table while a clinician's glove is seen placing an oxygen mask over her nose and mouth
Health Lab
Hispanic patients with respiratory failure much more likely to be oversedated
Hispanic individuals who are hospitalized with respiratory failure are five times more likely than non-Hispanic patients to receive deep sedation while on a ventilator, according to a new study published in the Annals of the American Thoracic Society.
Illustration of a doctor and patient looking at ultrasound
Health Lab
Novel device detects cervix “ripening” to predict normal and abnormal labor
Multi-specialty team is studying a non-invasive method to measure underlying cervical tissue changes that precede birth with the hopes of predicting timing of birth.